chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Nausea
Clinical narrative: Headache; migraine; chills; muscle soreness; tiredness; lethargy; loss of appetite; nausea; This is a spontaneous report from a contactable other healthcare professional. A 42-years-old non-pregnant female patient received second dose of BNT162B2 (COMIRNATY, Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EM9810), via an unspecified route of administration, administered on Arm Left on 02Feb2021 11:15 (Age at vaccination: 42 years) as SINGLE dose for covid-19 immunization at Health Clinic/Administration facility. The patient's medical history included asthma from an unknown date, drug hypersensitivity from an unknown date for allergies: penicillin, sulfa drugs, ceclor and Tylenol. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient Concomitant medications within 2 weeks of vaccination included vitamin D NOS (VITAMIN D NOS) for an unspecified indication from an unknown start date. On 12 Jan2021 at 11:45, The patient previously received first dose of BNT162B2 (COMIRNATY, Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EL3248), via an unspecified route of administration administered on Arm Left as SINGLE dose for COVID-19 immunization. On 03Feb2021 at 3:00 the patient experienced Headache- migraine, chills, muscle soreness, tiredness/ lethargy, loss of appetite with nausea. The seriousness criteria of the events has not resulted in death, Life threatening, Caused/prolonged hospitalization, Disabling/Incapacitating, Congenital anomaly/birth defect. The patient did not receive any treatment for the events. The outcome of the events was reported as recovered.  The events was considered as non-serious.  Follow-up attempts are completed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Decreased appetite, Fatigue, Headache, Lethargy
Clinical narrative: Headache; migraine; chills; muscle soreness; tiredness; lethargy; loss of appetite; nausea; This is a spontaneous report from a contactable other healthcare professional. A 42-years-old non-pregnant female patient received second dose of BNT162B2 (COMIRNATY, Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EM9810), via an unspecified route of administration, administered on Arm Left on 02Feb2021 11:15 (Age at vaccination: 42 years) as SINGLE dose for covid-19 immunization at Health Clinic/Administration facility. The patient's medical history included asthma from an unknown date, drug hypersensitivity from an unknown date for allergies: penicillin, sulfa drugs, ceclor and Tylenol. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient Concomitant medications within 2 weeks of vaccination included vitamin D NOS (VITAMIN D NOS) for an unspecified indication from an unknown start date. On 12 Jan2021 at 11:45, The patient previously received first dose of BNT162B2 (COMIRNATY, Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EL3248), via an unspecified route of administration administered on Arm Left as SINGLE dose for COVID-19 immunization. On 03Feb2021 at 3:00 the patient experienced Headache- migraine, chills, muscle soreness, tiredness/ lethargy, loss of appetite with nausea. The seriousness criteria of the events has not resulted in death, Life threatening, Caused/prolonged hospitalization, Disabling/Incapacitating, Congenital anomaly/birth defect. The patient did not receive any treatment for the events. The outcome of the events was reported as recovered.  The events was considered as non-serious.  Follow-up attempts are completed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Migraine, Myalgia, Nausea
Clinical narrative: Headache; migraine; chills; muscle soreness; tiredness; lethargy; loss of appetite; nausea; This is a spontaneous report from a contactable other healthcare professional. A 42-years-old non-pregnant female patient received second dose of BNT162B2 (COMIRNATY, Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EM9810), via an unspecified route of administration, administered on Arm Left on 02Feb2021 11:15 (Age at vaccination: 42 years) as SINGLE dose for covid-19 immunization at Health Clinic/Administration facility. The patient's medical history included asthma from an unknown date, drug hypersensitivity from an unknown date for allergies: penicillin, sulfa drugs, ceclor and Tylenol. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient Concomitant medications within 2 weeks of vaccination included vitamin D NOS (VITAMIN D NOS) for an unspecified indication from an unknown start date. On 12 Jan2021 at 11:45, The patient previously received first dose of BNT162B2 (COMIRNATY, Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EL3248), via an unspecified route of administration administered on Arm Left as SINGLE dose for COVID-19 immunization. On 03Feb2021 at 3:00 the patient experienced Headache- migraine, chills, muscle soreness, tiredness/ lethargy, loss of appetite with nausea. The seriousness criteria of the events has not resulted in death, Life threatening, Caused/prolonged hospitalization, Disabling/Incapacitating, Congenital anomaly/birth defect. The patient did not receive any treatment for the events. The outcome of the events was reported as recovered.  The events was considered as non-serious.  Follow-up attempts are completed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Dizziness, Feeling cold, Headache, Nausea
Clinical narrative: headache; chills; dizziness; This is a spontaneous report from a contactable other-HCP (patient). A 47-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: eh5318), via an unspecified route of administration, administered in left arm on 14Feb2021 16:45 as single dose for covid-19 immunization. Medical history included diabetes mellitus. Patient experienced allergies to sulfamate and penicillin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Concomitant medication(s) included metformin (METFORMIN) for unspecified indication from unknown date. On 15Feb2021 13:00, patient experienced headache, chills, dizziness and temperature. Therapeutic measures were not taken for the events. The outcome of event was unknown.   Follow-up (12May2021): This follow-up is being submitted to notify that the lot/batch number was not available despite the follow-up attempts made.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: headache; chills; dizziness; This is a spontaneous report from a contactable other-HCP (patient). A 47-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: eh5318), via an unspecified route of administration, administered in left arm on 14Feb2021 16:45 as single dose for covid-19 immunization. Medical history included diabetes mellitus. Patient experienced allergies to sulfamate and penicillin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Concomitant medication(s) included metformin (METFORMIN) for unspecified indication from unknown date. On 15Feb2021 13:00, patient experienced headache, chills, dizziness and temperature. Therapeutic measures were not taken for the events. The outcome of event was unknown.   Follow-up (12May2021): This follow-up is being submitted to notify that the lot/batch number was not available despite the follow-up attempts made.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Dizziness, Headache
Clinical narrative: headache; chills; dizziness; This is a spontaneous report from a contactable other-HCP (patient). A 47-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: eh5318), via an unspecified route of administration, administered in left arm on 14Feb2021 16:45 as single dose for covid-19 immunization. Medical history included diabetes mellitus. Patient experienced allergies to sulfamate and penicillin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Concomitant medication(s) included metformin (METFORMIN) for unspecified indication from unknown date. On 15Feb2021 13:00, patient experienced headache, chills, dizziness and temperature. Therapeutic measures were not taken for the events. The outcome of event was unknown.   Follow-up (12May2021): This follow-up is being submitted to notify that the lot/batch number was not available despite the follow-up attempts made.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Rash, Rash erythematous, Rash pruritic, Skin warm
Clinical narrative: severe hives; welts were very red, warm to touch and raised; itchy rash/it was itchy; she broke out in a rash/hives in between her breasts and underneath her breasts; welts were very red, warm to touch and raised; She had a sore arm for a couple of days; This is a spontaneous report from a contactable Consumer (patient herself). A 67-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EM9809, Expiry Date: unknown) on 10Feb2021 06:00 PM via unspecified route of administration at 1ST DOSE, SINGLE for COVID-19 immunization. The patient's medical history included hypertension. The patient's allergic conditions included Penicillin, Ampicillin. The patient did not have covid prior to vaccination. The patient did not have any other vaccine in four weeks. The patient's concomitant medications included Losartan, Colace, Aleve, Motrin, Tylenol. On an unknown date in Feb2021, after receiving her vaccine, the patient had a sore arm for 3 days. On 14Feb2021, the patient broke out in itchy rash/hives in between her breasts and underneath her breasts. The patient stated it was itchy, she applied Clobetasol cream, and it seemed to improve. On 15Feb2021, at 3:30 am in the morning the patient broke out in severe hives (large welts) along both sides of her abdomen more pronounced on the left side, under the patient's abdomen and in the groin area. It then started spreading to the patient's upper body. The patient described the rash as very red, raised, itchy and warm to touch. The patient had no shortness of breath or swelling of her face or throat. At 4 am, the patient took a Benadryl (25mg) and applied more Clobetasol cream. The patient stated that the welts were very red, warm to touch and raised. The patient then took another Benadryl (25mg) at 5 am because there was not much improvement. The patient reported, at 9 am the hives were still present but not as raised, red or itchy. The patient took another Benadryl (25mg) in the afternoon, but it still had not resolved completely. The patient also stated that there was no change in the diet, medications, laundry detergent or bath soap. The outcome of the events was reported as not recovered.  Follow up information has been requested.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: severe hives; welts were very red, warm to touch and raised; itchy rash/it was itchy; she broke out in a rash/hives in between her breasts and underneath her breasts; welts were very red, warm to touch and raised; She had a sore arm for a couple of days; This is a spontaneous report from a contactable Consumer (patient herself). A 67-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EM9809, Expiry Date: unknown) on 10Feb2021 06:00 PM via unspecified route of administration at 1ST DOSE, SINGLE for COVID-19 immunization. The patient's medical history included hypertension. The patient's allergic conditions included Penicillin, Ampicillin. The patient did not have covid prior to vaccination. The patient did not have any other vaccine in four weeks. The patient's concomitant medications included Losartan, Colace, Aleve, Motrin, Tylenol. On an unknown date in Feb2021, after receiving her vaccine, the patient had a sore arm for 3 days. On 14Feb2021, the patient broke out in itchy rash/hives in between her breasts and underneath her breasts. The patient stated it was itchy, she applied Clobetasol cream, and it seemed to improve. On 15Feb2021, at 3:30 am in the morning the patient broke out in severe hives (large welts) along both sides of her abdomen more pronounced on the left side, under the patient's abdomen and in the groin area. It then started spreading to the patient's upper body. The patient described the rash as very red, raised, itchy and warm to touch. The patient had no shortness of breath or swelling of her face or throat. At 4 am, the patient took a Benadryl (25mg) and applied more Clobetasol cream. The patient stated that the welts were very red, warm to touch and raised. The patient then took another Benadryl (25mg) at 5 am because there was not much improvement. The patient reported, at 9 am the hives were still present but not as raised, red or itchy. The patient took another Benadryl (25mg) in the afternoon, but it still had not resolved completely. The patient also stated that there was no change in the diet, medications, laundry detergent or bath soap. The outcome of the events was reported as not recovered.  Follow up information has been requested.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Feeling hot, Pain in extremity, Rash, Rash pruritic
Clinical narrative: severe hives; welts were very red, warm to touch and raised; itchy rash/it was itchy; she broke out in a rash/hives in between her breasts and underneath her breasts; welts were very red, warm to touch and raised; She had a sore arm for a couple of days; This is a spontaneous report from a contactable Consumer (patient herself). A 67-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EM9809, Expiry Date: unknown) on 10Feb2021 06:00 PM via unspecified route of administration at 1ST DOSE, SINGLE for COVID-19 immunization. The patient's medical history included hypertension. The patient's allergic conditions included Penicillin, Ampicillin. The patient did not have covid prior to vaccination. The patient did not have any other vaccine in four weeks. The patient's concomitant medications included Losartan, Colace, Aleve, Motrin, Tylenol. On an unknown date in Feb2021, after receiving her vaccine, the patient had a sore arm for 3 days. On 14Feb2021, the patient broke out in itchy rash/hives in between her breasts and underneath her breasts. The patient stated it was itchy, she applied Clobetasol cream, and it seemed to improve. On 15Feb2021, at 3:30 am in the morning the patient broke out in severe hives (large welts) along both sides of her abdomen more pronounced on the left side, under the patient's abdomen and in the groin area. It then started spreading to the patient's upper body. The patient described the rash as very red, raised, itchy and warm to touch. The patient had no shortness of breath or swelling of her face or throat. At 4 am, the patient took a Benadryl (25mg) and applied more Clobetasol cream. The patient stated that the welts were very red, warm to touch and raised. The patient then took another Benadryl (25mg) at 5 am because there was not much improvement. The patient reported, at 9 am the hives were still present but not as raised, red or itchy. The patient took another Benadryl (25mg) in the afternoon, but it still had not resolved completely. The patient also stated that there was no change in the diet, medications, laundry detergent or bath soap. The outcome of the events was reported as not recovered.  Follow up information has been requested.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Dehydration, Gait inability, Headache, Impaired work ability
Clinical narrative: expressive aphasia; This is a spontaneous report from a contactable physician. A 37-Year-old non-pregnant female patient received first dose of BNT162B2 (solution for injection) via intramuscular (administered in arm left) on 04Feb2021 (at the time of 37-year-old) at single dose for COVID-19 immunisation. The patient medical history included migraines, depression, ADD (attention deficit hyperactivity disorder), fibromyalgia and insomnia. Concomitant medications were not reported. The patient previously took erythromycin and experienced allergies. On 05Feb2021 the patient experienced expressive aphasia. Adverse event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Patient didn't receive any treatment for the event. The outcome of the event was not recovered.  Information on the Lot/batch number has been requested.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Pain, Speech disorder
Clinical narrative: expressive aphasia; This is a spontaneous report from a contactable physician. A 37-Year-old non-pregnant female patient received first dose of BNT162B2 (solution for injection) via intramuscular (administered in arm left) on 04Feb2021 (at the time of 37-year-old) at single dose for COVID-19 immunisation. The patient medical history included migraines, depression, ADD (attention deficit hyperactivity disorder), fibromyalgia and insomnia. Concomitant medications were not reported. The patient previously took erythromycin and experienced allergies. On 05Feb2021 the patient experienced expressive aphasia. Adverse event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Patient didn't receive any treatment for the event. The outcome of the event was not recovered.  Information on the Lot/batch number has been requested.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Aphasia
Clinical narrative: expressive aphasia; This is a spontaneous report from a contactable physician. A 37-Year-old non-pregnant female patient received first dose of BNT162B2 (solution for injection) via intramuscular (administered in arm left) on 04Feb2021 (at the time of 37-year-old) at single dose for COVID-19 immunisation. The patient medical history included migraines, depression, ADD (attention deficit hyperactivity disorder), fibromyalgia and insomnia. Concomitant medications were not reported. The patient previously took erythromycin and experienced allergies. On 05Feb2021 the patient experienced expressive aphasia. Adverse event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Patient didn't receive any treatment for the event. The outcome of the event was not recovered.  Information on the Lot/batch number has been requested.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal distension, Gait disturbance, Groin pain
Clinical narrative: Had pain& pressure in groin area; Had pain& pressure in groin area; This is a spontaneous report from a contactable consumer or other non hcp. A 68-years-old female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: EN5318; Expiration Date: unknown), dose 2 via an unspecified route of administration, administered in Arm Left on 11Feb2021 12:00 (Batch/Lot Number: EN5318) as 2nd dose, single; dose 1 on 21Jan2021, 12:00 as 1st dose, single (lot number: EL1283) in left arm for COVID-19 immunization. Medical history included rheumatoid arthritis, allergic sinusitis, food allergy from an unknown date. The patient's concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.   The patient previously took bnt162b2, z-pak and experienced drug hypersensitivity. On 11Feb2021, 12:00 the patient experienced pain& pressure in groin area. The patient had recovered from the events..     Information on Lot/Batch number was available. Additional information has been requested.
Age: 68.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Groin pain, Muscle strain
Clinical narrative: Had pain& pressure in groin area; Had pain& pressure in groin area; This is a spontaneous report from a contactable consumer or other non hcp. A 68-years-old female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: EN5318; Expiration Date: unknown), dose 2 via an unspecified route of administration, administered in Arm Left on 11Feb2021 12:00 (Batch/Lot Number: EN5318) as 2nd dose, single; dose 1 on 21Jan2021, 12:00 as 1st dose, single (lot number: EL1283) in left arm for COVID-19 immunization. Medical history included rheumatoid arthritis, allergic sinusitis, food allergy from an unknown date. The patient's concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.   The patient previously took bnt162b2, z-pak and experienced drug hypersensitivity. On 11Feb2021, 12:00 the patient experienced pain& pressure in groin area. The patient had recovered from the events..     Information on Lot/Batch number was available. Additional information has been requested.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypoaesthesia oral, Paraesthesia oral
Clinical narrative: was waiting mouth/tongue got numb, little constriction throat little bit numbness; was waiting mouth/tongue got numb, little constriction throat little bit numbness; This is a spontaneous report from a contactable Other HCP (Nurse) (Patient). A 71-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection,) via an unspecified route of administration on an unspecified date (Batch/Lot number: Unknown) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. On an unknown date the patient stated was waiting mouth/tongue got numb, little constriction throat little bit numbness and enquired should she get the second dose. The events considered as non-serious. The outcome of events was unknown. The action taken in response to the events for bnt162b2 was not applicable.  Information on the lot/batch number has been requested.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypoaesthesia oral, Pharyngeal hypoaesthesia
Clinical narrative: was waiting mouth/tongue got numb, little constriction throat little bit numbness; was waiting mouth/tongue got numb, little constriction throat little bit numbness; This is a spontaneous report from a contactable Other HCP (Nurse) (Patient). A 71-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection,) via an unspecified route of administration on an unspecified date (Batch/Lot number: Unknown) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. On an unknown date the patient stated was waiting mouth/tongue got numb, little constriction throat little bit numbness and enquired should she get the second dose. The events considered as non-serious. The outcome of events was unknown. The action taken in response to the events for bnt162b2 was not applicable.  Information on the lot/batch number has been requested.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest discomfort, Hypoaesthesia, Hypoaesthesia oral, Throat tightness
Clinical narrative: was waiting mouth/tongue got numb, little constriction throat little bit numbness; was waiting mouth/tongue got numb, little constriction throat little bit numbness; This is a spontaneous report from a contactable Other HCP (Nurse) (Patient). A 71-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection,) via an unspecified route of administration on an unspecified date (Batch/Lot number: Unknown) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. On an unknown date the patient stated was waiting mouth/tongue got numb, little constriction throat little bit numbness and enquired should she get the second dose. The events considered as non-serious. The outcome of events was unknown. The action taken in response to the events for bnt162b2 was not applicable.  Information on the lot/batch number has been requested.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Bedridden, Chills, Confusional state, Myalgia
Clinical narrative: Red Rash over entire body, severely dry skin over entire body.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: Red Rash over entire body, severely dry skin over entire body.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dry skin, Rash, Rash erythematous
Clinical narrative: Red Rash over entire body, severely dry skin over entire body.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Injection site reaction, Rash, Rash morbilliform, Rash pruritic, Urticaria
Clinical narrative: rash/on chest bilaterally; This is spontaneous report received from contactable other-HCP on behalf of the patient. A 72 -year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL9264), via an Intramuscular route of administration, administered in left arm on 11Feb2021 (at the age of 72-years) as a single dose for COVID-19 immunization. The patient medical history included GERD, hyperlipidaemia, CLL, DJD. The patient had no known allergies. Patient did not receive any other vaccine four weeks prior vaccination. Patient not had COVID prior vaccination. Concomitant medications included amlodipine, celebrex, lipitor, omeprazole. On 11Feb2021 (same day after vaccination), patient experienced rash on chest bilaterally. Patient visited dermatologist as a result of event. Patient was treated with triamcinolone. Patient was not tested for COVID post vaccination. The outcome of the event rash was recovering.   No Follow-up attempts are needed. No further information is expected.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Rash
Clinical narrative: rash/on chest bilaterally; This is spontaneous report received from contactable other-HCP on behalf of the patient. A 72 -year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL9264), via an Intramuscular route of administration, administered in left arm on 11Feb2021 (at the age of 72-years) as a single dose for COVID-19 immunization. The patient medical history included GERD, hyperlipidaemia, CLL, DJD. The patient had no known allergies. Patient did not receive any other vaccine four weeks prior vaccination. Patient not had COVID prior vaccination. Concomitant medications included amlodipine, celebrex, lipitor, omeprazole. On 11Feb2021 (same day after vaccination), patient experienced rash on chest bilaterally. Patient visited dermatologist as a result of event. Patient was treated with triamcinolone. Patient was not tested for COVID post vaccination. The outcome of the event rash was recovering.   No Follow-up attempts are needed. No further information is expected.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Balance disorder, Blood glucose, Blood glucose decreased, Computerised tomogram, Dizziness
Clinical narrative: RECEIVE 2ND SHOT 0N 02-18-2021 and on 02-21-2021 Low Blood sugar. called 911 went to emergency.  For the next following week and a half blood sugar remained 50 - 80.  Dr. stop Gilipizide and blood rises bay to normal.  On March 4, 2021 Felt very dizzy and continue to fall each time i got up, called emergency.  Took CAT Scan and MRI.  March 6, 2021 been having bad headaches (never experience bad headaches); Took routine urine test, Urine Microalbumin; on March 21, 2021 test result highest results, 45.6 ug/mg.  During time to date lost approximately 8 pounds.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fall, Headache, Magnetic resonance imaging, Pain in extremity, Vertigo
Clinical narrative: RECEIVE 2ND SHOT 0N 02-18-2021 and on 02-21-2021 Low Blood sugar. called 911 went to emergency.  For the next following week and a half blood sugar remained 50 - 80.  Dr. stop Gilipizide and blood rises bay to normal.  On March 4, 2021 Felt very dizzy and continue to fall each time i got up, called emergency.  Took CAT Scan and MRI.  March 6, 2021 been having bad headaches (never experience bad headaches); Took routine urine test, Urine Microalbumin; on March 21, 2021 test result highest results, 45.6 ug/mg.  During time to date lost approximately 8 pounds.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Albumin urine present, Blood glucose decreased, Blood test, Computerised tomogram head, Dizziness
Clinical narrative: RECEIVE 2ND SHOT 0N 02-18-2021 and on 02-21-2021 Low Blood sugar. called 911 went to emergency.  For the next following week and a half blood sugar remained 50 - 80.  Dr. stop Gilipizide and blood rises bay to normal.  On March 4, 2021 Felt very dizzy and continue to fall each time i got up, called emergency.  Took CAT Scan and MRI.  March 6, 2021 been having bad headaches (never experience bad headaches); Took routine urine test, Urine Microalbumin; on March 21, 2021 test result highest results, 45.6 ug/mg.  During time to date lost approximately 8 pounds.
Age: 67.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fall, Headache, Magnetic resonance imaging head, Urine analysis, Weight decreased
Clinical narrative: RECEIVE 2ND SHOT 0N 02-18-2021 and on 02-21-2021 Low Blood sugar. called 911 went to emergency.  For the next following week and a half blood sugar remained 50 - 80.  Dr. stop Gilipizide and blood rises bay to normal.  On March 4, 2021 Felt very dizzy and continue to fall each time i got up, called emergency.  Took CAT Scan and MRI.  March 6, 2021 been having bad headaches (never experience bad headaches); Took routine urine test, Urine Microalbumin; on March 21, 2021 test result highest results, 45.6 ug/mg.  During time to date lost approximately 8 pounds.
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cold sweat, Dizziness, Drug hypersensitivity, Fatigue, Somnolence
Clinical narrative: 10 mins after injection became very faint and broke out in cold sweat. Pharmacy gave me oral Benadryl. For the next three days i was very fatigues and slept 60% of the time. Starting on day 4 my upper back and neck started to very pain like a sunburn feeling, but the skin was not red and there was no rash and did not hurt when touched. The sunburn feeling was constant and annoying from day 4-14, then it started to become more intermittent. I decided to get the second vaccine shot(Pfizer ER8734) on 4/5/21. Since that time the sunburn feeling has spread to my shoulders and arms and the inside of my legs. As of this date it is pretty much a constant pain. In the last couple of weeks I have also started feeling random nerve pain on all different parts of my body.
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Sunburn, Syncope, Tenderness
Clinical narrative: 10 mins after injection became very faint and broke out in cold sweat. Pharmacy gave me oral Benadryl. For the next three days i was very fatigues and slept 60% of the time. Starting on day 4 my upper back and neck started to very pain like a sunburn feeling, but the skin was not red and there was no rash and did not hurt when touched. The sunburn feeling was constant and annoying from day 4-14, then it started to become more intermittent. I decided to get the second vaccine shot(Pfizer ER8734) on 4/5/21. Since that time the sunburn feeling has spread to my shoulders and arms and the inside of my legs. As of this date it is pretty much a constant pain. In the last couple of weeks I have also started feeling random nerve pain on all different parts of my body.
Age: 57.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Burning sensation, Neuralgia, Pain in extremity
Clinical narrative: 10 mins after injection became very faint and broke out in cold sweat. Pharmacy gave me oral Benadryl. For the next three days i was very fatigues and slept 60% of the time. Starting on day 4 my upper back and neck started to very pain like a sunburn feeling, but the skin was not red and there was no rash and did not hurt when touched. The sunburn feeling was constant and annoying from day 4-14, then it started to become more intermittent. I decided to get the second vaccine shot(Pfizer ER8734) on 4/5/21. Since that time the sunburn feeling has spread to my shoulders and arms and the inside of my legs. As of this date it is pretty much a constant pain. In the last couple of weeks I have also started feeling random nerve pain on all different parts of my body.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaphylactic reaction, Blood potassium decreased, Chest discomfort, Dyspnoea, SARS-CoV-2 test negative
Clinical narrative: Feel both my arms and my neck start to itch and burn; Feel both my arms and my neck start to itch and burn; My chest started feeling heavy; Trouble breathing; Wheezing; Was not able to speak very well; Inflamed throat; Not much movement in my lungs; This is a spontaneous report from a contactable consumer (patient). A 29-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration in right arm at age of 29-years, on 27Mar2021 14:30 (Lot Number: Unknown) as single dose for COVID-19 immunisation. Medical history included allergies to pork and cow milk; she had asthma and paralysis. The patient was not pregnant at time of vaccination. Concomitant medication included amitriptyline and "nurtec odt" (received within 2 weeks of vaccination). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced both arms and her neck start to itch and burn. Then her chest started feeling heavy, then trouble breathing and wheezing. She was not able to speak very well, inflamed throat and not much movement in her lungs. She was sent to ICU. The adverse event result in hospitalization and "Doctor or other healthcare professional office/clinic visit". Adverse events started at 14:45 on 27Mar2021. She was hospitalized for 7 days. The treatment for events included Epi, steroids, dual nebulizer benedryl. The patient did not diagnose with COVID-19 prior to vaccination. She tested for COVID-19 with Nasal Swab since the vaccination on 27Mar2021 with outcome was negative. Events outcome was recovering.  Information on the lot/batch number has been requested.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Stridor, Vocal cord inflammation
Clinical narrative: Feel both my arms and my neck start to itch and burn; Feel both my arms and my neck start to itch and burn; My chest started feeling heavy; Trouble breathing; Wheezing; Was not able to speak very well; Inflamed throat; Not much movement in my lungs; This is a spontaneous report from a contactable consumer (patient). A 29-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration in right arm at age of 29-years, on 27Mar2021 14:30 (Lot Number: Unknown) as single dose for COVID-19 immunisation. Medical history included allergies to pork and cow milk; she had asthma and paralysis. The patient was not pregnant at time of vaccination. Concomitant medication included amitriptyline and "nurtec odt" (received within 2 weeks of vaccination). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced both arms and her neck start to itch and burn. Then her chest started feeling heavy, then trouble breathing and wheezing. She was not able to speak very well, inflamed throat and not much movement in her lungs. She was sent to ICU. The adverse event result in hospitalization and "Doctor or other healthcare professional office/clinic visit". Adverse events started at 14:45 on 27Mar2021. She was hospitalized for 7 days. The treatment for events included Epi, steroids, dual nebulizer benedryl. The patient did not diagnose with COVID-19 prior to vaccination. She tested for COVID-19 with Nasal Swab since the vaccination on 27Mar2021 with outcome was negative. Events outcome was recovering.  Information on the lot/batch number has been requested.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Chest discomfort, Dyspnoea, Lung disorder, Pharyngeal inflammation
Clinical narrative: Feel both my arms and my neck start to itch and burn; Feel both my arms and my neck start to itch and burn; My chest started feeling heavy; Trouble breathing; Wheezing; Was not able to speak very well; Inflamed throat; Not much movement in my lungs; This is a spontaneous report from a contactable consumer (patient). A 29-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration in right arm at age of 29-years, on 27Mar2021 14:30 (Lot Number: Unknown) as single dose for COVID-19 immunisation. Medical history included allergies to pork and cow milk; she had asthma and paralysis. The patient was not pregnant at time of vaccination. Concomitant medication included amitriptyline and "nurtec odt" (received within 2 weeks of vaccination). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced both arms and her neck start to itch and burn. Then her chest started feeling heavy, then trouble breathing and wheezing. She was not able to speak very well, inflamed throat and not much movement in her lungs. She was sent to ICU. The adverse event result in hospitalization and "Doctor or other healthcare professional office/clinic visit". Adverse events started at 14:45 on 27Mar2021. She was hospitalized for 7 days. The treatment for events included Epi, steroids, dual nebulizer benedryl. The patient did not diagnose with COVID-19 prior to vaccination. She tested for COVID-19 with Nasal Swab since the vaccination on 27Mar2021 with outcome was negative. Events outcome was recovering.  Information on the lot/batch number has been requested.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, SARS-CoV-2 test, Speech disorder, Wheezing
Clinical narrative: Feel both my arms and my neck start to itch and burn; Feel both my arms and my neck start to itch and burn; My chest started feeling heavy; Trouble breathing; Wheezing; Was not able to speak very well; Inflamed throat; Not much movement in my lungs; This is a spontaneous report from a contactable consumer (patient). A 29-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration in right arm at age of 29-years, on 27Mar2021 14:30 (Lot Number: Unknown) as single dose for COVID-19 immunisation. Medical history included allergies to pork and cow milk; she had asthma and paralysis. The patient was not pregnant at time of vaccination. Concomitant medication included amitriptyline and "nurtec odt" (received within 2 weeks of vaccination). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced both arms and her neck start to itch and burn. Then her chest started feeling heavy, then trouble breathing and wheezing. She was not able to speak very well, inflamed throat and not much movement in her lungs. She was sent to ICU. The adverse event result in hospitalization and "Doctor or other healthcare professional office/clinic visit". Adverse events started at 14:45 on 27Mar2021. She was hospitalized for 7 days. The treatment for events included Epi, steroids, dual nebulizer benedryl. The patient did not diagnose with COVID-19 prior to vaccination. She tested for COVID-19 with Nasal Swab since the vaccination on 27Mar2021 with outcome was negative. Events outcome was recovering.  Information on the lot/batch number has been requested.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest pain, Dyspnoea, Throat tightness, Urticaria, Wheezing
Clinical narrative: epinephrine, diphenhydramine, steroids
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: epinephrine, diphenhydramine, steroids
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anaphylactic reaction, Chest discomfort, Confusional state, Heart rate increased, Hypoaesthesia
Clinical narrative: epinephrine, diphenhydramine, steroids
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypotension, Immediate post-injection reaction, Muscle tightness, Swelling face, Throat tightness
Clinical narrative: epinephrine, diphenhydramine, steroids
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Urticaria, Wheezing
Clinical narrative: epinephrine, diphenhydramine, steroids
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Ataxia, Dysarthria, Hypoaesthesia
Clinical narrative: Guillan Barre Syndrome
Age: 66.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Guillain-Barre syndrome, Neurological examination
Clinical narrative: Guillan Barre Syndrome
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Biopsy skin, Blood test, Dermatitis bullous, Musculoskeletal stiffness, Neck pain
Clinical narrative: I was vaccinated on 01/20/21. On 02/11/21 I started having stiffness in my neck. On 02/15/21 it got worse and could not turn my head as the neck was stiff and swollen. My neck got better after few days and the pain moved to both my biceps. They were also swollen and painful. After few days the pain was gone but I started having pain on both my thighs. They were also swollen and very painful. After few days the pain disappeared and it moved to both legs and feet. At that same time my skin was also getting inflamed and peeling off.  I could not even take a shower or bath as the skin was very sensitive and painful.  I also started developing some blisters on most parts of my body. It was diagnosed a Bullous Pemphigoid.
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Oedema peripheral, Rash erythematous
Clinical narrative: I was vaccinated on 01/20/21. On 02/11/21 I started having stiffness in my neck. On 02/15/21 it got worse and could not turn my head as the neck was stiff and swollen. My neck got better after few days and the pain moved to both my biceps. They were also swollen and painful. After few days the pain was gone but I started having pain on both my thighs. They were also swollen and very painful. After few days the pain disappeared and it moved to both legs and feet. At that same time my skin was also getting inflamed and peeling off.  I could not even take a shower or bath as the skin was very sensitive and painful.  I also started developing some blisters on most parts of my body. It was diagnosed a Bullous Pemphigoid.
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Biopsy, Blister, Blood albumin decreased, Blood glucose increased, Dermatitis
Clinical narrative: I was vaccinated on 01/20/21. On 02/11/21 I started having stiffness in my neck. On 02/15/21 it got worse and could not turn my head as the neck was stiff and swollen. My neck got better after few days and the pain moved to both my biceps. They were also swollen and painful. After few days the pain was gone but I started having pain on both my thighs. They were also swollen and very painful. After few days the pain disappeared and it moved to both legs and feet. At that same time my skin was also getting inflamed and peeling off.  I could not even take a shower or bath as the skin was very sensitive and painful.  I also started developing some blisters on most parts of my body. It was diagnosed a Bullous Pemphigoid.
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dry skin, Eosinophil count increased, Musculoskeletal stiffness, Pain in extremity, Pain of skin
Clinical narrative: I was vaccinated on 01/20/21. On 02/11/21 I started having stiffness in my neck. On 02/15/21 it got worse and could not turn my head as the neck was stiff and swollen. My neck got better after few days and the pain moved to both my biceps. They were also swollen and painful. After few days the pain was gone but I started having pain on both my thighs. They were also swollen and very painful. After few days the pain disappeared and it moved to both legs and feet. At that same time my skin was also getting inflamed and peeling off.  I could not even take a shower or bath as the skin was very sensitive and painful.  I also started developing some blisters on most parts of my body. It was diagnosed a Bullous Pemphigoid.
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pemphigoid, Peripheral swelling, Pruritus, Skin discolouration, Skin exfoliation
Clinical narrative: I was vaccinated on 01/20/21. On 02/11/21 I started having stiffness in my neck. On 02/15/21 it got worse and could not turn my head as the neck was stiff and swollen. My neck got better after few days and the pain moved to both my biceps. They were also swollen and painful. After few days the pain was gone but I started having pain on both my thighs. They were also swollen and very painful. After few days the pain disappeared and it moved to both legs and feet. At that same time my skin was also getting inflamed and peeling off.  I could not even take a shower or bath as the skin was very sensitive and painful.  I also started developing some blisters on most parts of my body. It was diagnosed a Bullous Pemphigoid.
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Swelling
Clinical narrative: I was vaccinated on 01/20/21. On 02/11/21 I started having stiffness in my neck. On 02/15/21 it got worse and could not turn my head as the neck was stiff and swollen. My neck got better after few days and the pain moved to both my biceps. They were also swollen and painful. After few days the pain was gone but I started having pain on both my thighs. They were also swollen and very painful. After few days the pain disappeared and it moved to both legs and feet. At that same time my skin was also getting inflamed and peeling off.  I could not even take a shower or bath as the skin was very sensitive and painful.  I also started developing some blisters on most parts of my body. It was diagnosed a Bullous Pemphigoid.
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Slight soreness at site
Age: 16.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Injection site pain
Clinical narrative: Slight soreness at site
Age: 41.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Hypoaesthesia, Pain
Clinical narrative: 3 days after receiving the vaccine I started having a very painful shoulder pain as days passed the pain intensified in severity and I could feel the left side of my face num, my picky and ring finger on my left arm and numbness that went from my neck down to my spinal cord this was accompanied with a burning sensation.